JP2011508595A5 - - Google Patents

Download PDF

Info

Publication number
JP2011508595A5
JP2011508595A5 JP2010540954A JP2010540954A JP2011508595A5 JP 2011508595 A5 JP2011508595 A5 JP 2011508595A5 JP 2010540954 A JP2010540954 A JP 2010540954A JP 2010540954 A JP2010540954 A JP 2010540954A JP 2011508595 A5 JP2011508595 A5 JP 2011508595A5
Authority
JP
Japan
Prior art keywords
amino acid
acid segment
composition
derived
dna
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2010540954A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011508595A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2008/088678 external-priority patent/WO2009088950A2/en
Publication of JP2011508595A publication Critical patent/JP2011508595A/ja
Publication of JP2011508595A5 publication Critical patent/JP2011508595A5/ja
Pending legal-status Critical Current

Links

JP2010540954A 2007-12-31 2008-12-31 外来性アミノ酸の挿入を含むｐｃｖ２ｏｒｆ２ウイルス様粒子 Pending JP2011508595A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1786307P 2007-12-31 2007-12-31
PCT/US2008/088678 WO2009088950A2 (en) 2007-12-31 2008-12-31 Pcv2 orf2 virus like particle with foreign amino acid insertion

Publications (2)

Publication Number Publication Date
JP2011508595A JP2011508595A (ja) 2011-03-17
JP2011508595A5 true JP2011508595A5 (enExample) 2012-03-22

Family

ID=40853690

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010540954A Pending JP2011508595A (ja) 2007-12-31 2008-12-31 外来性アミノ酸の挿入を含むｐｃｖ２ｏｒｆ２ウイルス様粒子

Country Status (9)

Country Link
US (2) US20110020394A1 (enExample)
EP (1) EP2231182A4 (enExample)
JP (1) JP2011508595A (enExample)
KR (1) KR20100103535A (enExample)
CN (1) CN101932336B (enExample)
AU (1) AU2008347235A1 (enExample)
BR (1) BRPI0821456A2 (enExample)
CA (1) CA2710558A1 (enExample)
WO (1) WO2009088950A2 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101932336B (zh) * 2007-12-31 2014-07-09 贝林格尔.英格海姆维特梅迪卡有限公司 有外来氨基酸插入的pcv2 orf2病毒样颗粒
CN101773667A (zh) * 2010-01-28 2010-07-14 洛阳普莱柯生物工程有限公司 一种猪圆环病毒ii型疫苗制备
KR102153365B1 (ko) * 2018-03-19 2020-09-08 주식회사 옵티팜 신규한 바이러스 유사입자, 이를 포함하는 돼지 써코바이러스 3에 의한 질환에 대한 백신 조성물, 및 이의 제조 방법
WO2021033420A1 (ja) * 2019-08-20 2021-02-25 株式会社ジェクタス・イノベーターズ ブタサーコウイルス２型ｖｌｐワクチン
BR102019017792A2 (pt) * 2019-08-27 2021-11-16 Fundação Oswaldo Cruz Receptáculo proteico, método para produção do receptáculo, método de identificação de patógenos ou de diagnóstico de doenças, e, uso do receptáculo
CN116438202A (zh) * 2020-10-05 2023-07-14 勃林格殷格翰动物保健美国有限公司 包含圆环病毒科衣壳蛋白的融合蛋白及其构成的嵌合病毒样颗粒

Family Cites Families (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5202430A (en) * 1990-01-16 1993-04-13 University Of Tennessee Transmissible gastroenteritis virus genes
US5565205A (en) * 1990-08-16 1996-10-15 Solvay Animal Health, Inc. Inactivated Mycoplasma hypopneumoniae bacterin and method of use thereof
GB9023111D0 (en) * 1990-10-24 1990-12-05 Wellcome Found Expression system
WO1992007934A1 (en) * 1990-11-01 1992-05-14 Iowa State University Research Foundation, Inc. Bacterial attenuation method and vaccine
US5580557A (en) * 1991-10-09 1996-12-03 Iowa State University Research Foundation, Inc. Live, avirulent salmonella choleraesuis vaccine used for inducing an immune response in animals
US5338543A (en) * 1992-02-27 1994-08-16 Ambico, Inc. Thimerosal inactivated mycoplasma hyopneumoniae vaccine
US5885823A (en) * 1995-06-05 1999-03-23 Nobl Laboratories, Inc. Lawsonia intracellularis cultivation, anti-Lawsonia intracellularis vaccines and diagnostic agents
ES2157522T3 (es) * 1996-10-09 2001-08-16 Akzo Nobel Nv Cepas de vacunas europeas del virus del sindrome respiratorio reproductor porcino (prrsv).
US5735555A (en) * 1996-12-18 1998-04-07 Siemens Automotive Corporation Fuel rail to fuel tube end compact connector
US20060029617A1 (en) * 1997-10-03 2006-02-09 Charreyre Catherine E Porcine circovirus and Helicobacter combination vaccines and methods of use
US7211379B2 (en) * 1997-10-03 2007-05-01 Merial Sas Prevention of myocarditis, abortion and intrauterine infection associated with porcine circovirus-2
US6517843B1 (en) * 1999-08-31 2003-02-11 Merial Reduction of porcine circovirus-2 viral load with inactivated PCV-2
US6391314B1 (en) * 1997-10-03 2002-05-21 Merial Porcine circoviruses vaccines diagnostic reagents
UA78180C2 (uk) * 1997-10-03 2007-03-15 Меріаль Кільцевий вірус свині типу ii, вакцини та діагностичні реагенти
US7192594B2 (en) * 1997-10-03 2007-03-20 Merial Limited Postweaning multisystemic wasting syndrome and porcine circovirus from pigs
FR2781159B1 (fr) * 1998-07-06 2000-10-06 Merial Sas Vaccin circovirus et parvovirus porcin
FR2772047B1 (fr) * 1997-12-05 2004-04-09 Ct Nat D Etudes Veterinaires E Sequence genomique et polypeptides de circovirus associe a la maladie de l'amaigrissement du porcelet (map), applications au diagnostic et a la prevention et/ou au traitement de l'infection
US20040062775A1 (en) * 1997-12-05 2004-04-01 Agence Francaise De Securite Sanitaire Des Aliments Circovirus sequences associated with piglet weight loss disease (PWD)
JP3795751B2 (ja) * 1997-12-11 2006-07-12 ユニバーシティ オブ サスカッチェワン ブタからの離乳後多全身系消耗症候群ウイルス
WO1999045956A1 (en) * 1998-03-13 1999-09-16 University Of Georgia Research Foundation, Inc. Vaccines against circovirus infections
US6294176B1 (en) * 1998-07-10 2001-09-25 Schering-Plough Veterinary Corp. Recombinant raccoonpox virus and uses thereof as a vaccine in mammalian and avian species
FR2789695B1 (fr) * 1999-02-11 2003-03-07 Merial Sas Vecteurs et vaccins viraux a base d'adenovirus porcins recombines et replicatifs
US6497883B1 (en) * 1999-06-10 2002-12-24 Merial Porcine circovirus recombinant poxvirus vaccine
US6943152B1 (en) * 1999-06-10 2005-09-13 Merial DNA vaccine-PCV
US6808900B2 (en) * 2000-06-15 2004-10-26 Manitoba, University Of Cryptosporidium parvum antigens, antibodies thereto and diagnostic and therapeutic compositions thereof
US7018638B2 (en) * 2000-12-19 2006-03-28 Wyeth Mycoplasma hyopneumoniae bacterin vaccine
MY146518A (en) * 2001-03-27 2012-08-15 Univ Saskatchewan Methods to culture circovirus.
US20030096377A1 (en) * 2001-06-28 2003-05-22 Virginia Tech Intellectual Properties, Inc. Differential PCR-RFLP assay for detecting and distinguishing between nonpathogenic PCV-1 and pathogenic PCV-2
JP2005515162A (ja) * 2001-07-02 2005-05-26 ファイザー・プロダクツ・インク マイコプラズマ・ハイオニューモニエ（Ｍｙｃｏｐｌａｓｍａｈｙｏｐｎｅｕｍｏｎｉａｅ）を用いた単回ワクチン接種
US7361352B2 (en) * 2001-08-15 2008-04-22 Acambis, Inc. Influenza immunogen and vaccine
US7276353B2 (en) * 2001-12-12 2007-10-02 Virginia Tech Intellectual Properties, Inc. Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof
US7279166B2 (en) * 2001-12-12 2007-10-09 Virginia Tech Intellectual Properties, Inc. Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof
US6841364B2 (en) * 2002-01-22 2005-01-11 Protatek International, Inc. Infectious cDNA clones of porcine reproductive and respiratory syndrome virus and expression vectors thereof
US20030215455A1 (en) * 2002-05-14 2003-11-20 Bailey Reynolds Vaccine stabilizer and method of use
US7223207B1 (en) * 2002-09-13 2007-05-29 Simon Basyuk Exercise and massage device
CN1458167A (zh) * 2003-06-02 2003-11-26 中国农业科学院哈尔滨兽医研究所 截短表达的猪圆环病毒ⅱ型衣壳蛋白抗原及其应用
US7335361B2 (en) * 2003-06-09 2008-02-26 Animal Technology Institute Taiwan Fusion antigen used as vaccine
PL1651265T3 (pl) * 2003-07-24 2008-10-31 Merial Ltd Formulacje szczepionek zawierających emulsję olej w wodzie
CA2533559C (en) * 2003-07-25 2013-07-02 Boehringer Ingelheim Vetmedica, Inc. Lawsonia intracellularis of european origin and vaccines, diagnostic agents and methods of use thereof
FR2861731B1 (fr) * 2003-10-30 2006-02-24 Centre Nat Rech Scient Nouvelle proteine de fixation du phosphate, compositions pharmaceutiques la contenant et ses utilisations
CN1579553A (zh) * 2004-05-18 2005-02-16 浙江大学 Ii型猪圆环病毒核酸疫苗的制备方法及其应用
KR20070052273A (ko) * 2004-06-30 2007-05-21 아이디 바이오메디컬 코포레이션 오브 퀘벡 코로나바이러스 감염의 치료를 위한 백신 조성물
US7833707B2 (en) * 2004-12-30 2010-11-16 Boehringer Ingelheim Vetmedica, Inc. Methods of overexpression and recovery of porcine circovirus type 2 ORF2
US7700285B1 (en) * 2005-12-29 2010-04-20 Boehringer Ingelheim Vetmedica, Inc. PCV2 immunogenic compositions and methods of producing such compositions
CA2587321A1 (en) * 2005-01-13 2006-07-20 Boehringer Ingelheim Vetmedica Gmbh Improved prrs vaccines
US7300785B2 (en) * 2005-02-03 2007-11-27 Universiteit Ghent Culturing circular ssDNA viruses for the production of vaccines
US8834891B2 (en) * 2005-03-14 2014-09-16 Boehringer Ingelheim Vetmedica, Inc. Immunogenic compositions comprising Lawsonia intracellularis
MX2007012786A (es) * 2005-04-13 2008-01-11 Merial Ltd Ensayo para produccion de circovirus porcino.
US7691368B2 (en) * 2005-04-15 2010-04-06 Merial Limited Vaccine formulations
CA2635430A1 (en) * 2005-12-29 2007-08-23 Boehringer Ingelheim Vetmedica, Inc. Use of a pcv2 immunogenic composition for lessening clinical symptoms in pigs
DK2275132T3 (da) * 2005-12-29 2021-05-17 Boehringer Ingelheim Animal Health Usa Inc Multivalente pcv2-immunogeniske sammensætninger og fremgangsmåder til at fremstille dem
WO2008064299A2 (en) * 2006-11-22 2008-05-29 Boehringer Ingelheim Vetmedica, Inc. Methods of reducing porcine circovirus-associated disease outbreaks
US20090017064A1 (en) * 2007-07-10 2009-01-15 Wyeth Methods and Compositions for Immunizing Pigs Against Porcine Circovirus
US7829274B2 (en) * 2007-09-04 2010-11-09 Boehringer Ingelheim Vetmedica, Inc. Reduction of concomitant infections in pigs by the use of PCV2 antigen
CN101932336B (zh) * 2007-12-31 2014-07-09 贝林格尔.英格海姆维特梅迪卡有限公司 有外来氨基酸插入的pcv2 orf2病毒样颗粒

Similar Documents

Publication Publication Date Title
JP6553509B2 (ja) ウイルス様粒子の精製
Wang et al. Nanoclusters self-assembled from conformation-stabilized influenza M2e as broadly cross-protective influenza vaccines
CN102791286B (zh) 杯状病毒病毒样颗粒上靶定异源抗原的呈递
JP2012523246A5 (enExample)
HRP20160276T1 (hr) Pripravci za imuniziranje protiv bakterije staphylococcus aureus
JP2011501950A5 (enExample)
CN102481378A (zh) Hpv颗粒及其用途
JP2014507144A5 (ja) 慢性ｂ型肝炎感染症のための酵母系免疫療法組成物
CN115175696A (zh) 包含白喉毒素交叉反应物质（crm）氨基酸序列的蛋白颗粒及其用途
WO2009088256A8 (ko) 배큘로바이러스-기반 백신
CN113156135B (zh) 用于杆状病毒表达的亚单位抗原的标记系统及其用途
WO2011003100A4 (en) Compositions and methods for diagnosing and/or treating influenza infection
Wang et al. A bivalent virus-like particle based vaccine induces a balanced antibody response against both enterovirus 71 and norovirus in mice
JP2010532656A5 (enExample)
JP2010538619A5 (enExample)
Davenport et al. Phage-like particle vaccines are highly immunogenic and protect against pathogenic coronavirus infection and disease
Ryder et al. Soluble recombinant human metapneumovirus G protein is immunogenic but not protective
Binjawadagi et al. Development of a porcine reproductive and respiratory syndrome virus-like-particle-based vaccine and evaluation of its immunogenicity in pigs
KR20160009020A (ko) 헤마글루티닌의 개선된 안정성 및 효능
JP2010517544A5 (enExample)
Zhao et al. Development and efficacy evaluation of remodeled canine parvovirus-like particles displaying major antigenic epitopes of a giant panda derived canine distemper virus
Gillam et al. Epitope selection and their placement for increased virus neutralization in a novel vaccination strategy for porcine epidemic diarrhea virus utilizing the Hepatitis B virus core antigen
FR2819810A1 (fr) Peptides non glycosyles derives de la proteine g du vrs et leur utilisation dans un vaccin
Zhu et al. Protection against the H1N1 influenza virus using self-assembled nanoparticles formed by lumazine synthase and bearing the M2e peptide
CN102174091B (zh) 截短表达鸭瘟病毒重组囊膜gI蛋白及其制备方法与应用